BRIEF published on 07/09/2024 at 09:10, 1 year 4 months ago BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization Drug Development Pharmaceutical Market Master Services Agreement BioNxt Solutions Cladribine ODF
BRIEF published on 07/09/2024 at 09:10, 1 year 4 months ago BioNxt signe un accord-cadre de services avec une organisation internationale de recherche, de développement et de fabrication sous contrat Marché Pharmaceutique Développement De Médicaments Solutions BioNxt Cladribine ODF Contrat-cadre De Services
PRESS RELEASE published on 07/09/2024 at 09:05, 1 year 4 months ago BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization BioNxt Solutions Inc. signs master services agreement with German-based CRDMO for product development of oral dissolvable drug formulations BioNxt Solutions Inc. Product Development Master Services Agreement CRDMO Oral Dissolvable Drug Formulations
BRIEF published on 06/20/2024 at 01:05, 1 year 5 months ago BioNxt Solutions Closes Second Tranche of Private Placement Private Placement Common Shares Warrants Research Funding BioNxt Solutions
BRIEF published on 06/20/2024 at 01:05, 1 year 5 months ago BioNxt Solutions clôture la deuxième tranche de placement privé Placement Privé Actions Ordinaires Bons De Souscription Financement De La Recherche Solutions BioNxt
PRESS RELEASE published on 06/20/2024 at 01:00, 1 year 5 months ago BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement BioNxt Solutions Inc. closes the second tranche of non-brokered private placement, raising $270,000. Proceeds will fund research, development, and working capital Private Placement Common Shares Working Capital Research And Development BioNxt Solutions Inc.
BRIEF published on 04/26/2024 at 05:55, 1 year 7 months ago BioNxt Solutions Advances Cladribine Studies and Announces Financing Initiative Private Placement BioNxt Solutions Inc. Multiple Sclerosis Cladribine Program Pharmaceutical Development
BRIEF published on 04/26/2024 at 05:55, 1 year 7 months ago BioNxt Solutions fait progresser les études sur la cladribine et annonce une initiative de financement Placement Privé BioNxt Solutions Inc. Sclérose En Plaques Programme Cladribine Développement Pharmaceutique
PRESS RELEASE published on 04/26/2024 at 05:50, 1 year 7 months ago Bionxt Solutions Announces Odf Cladribine Update and Financing BioNxt Solutions Inc. advances Cladribine program to human bioavailability studies in Europe, targeting MS market. Announces private placement for research and development Private Placement BioNxt Solutions Inc. Cladribine Program Bioavailability Studies Multiple Sclerosis Market
BRIEF published on 03/18/2024 at 08:10, 1 year 8 months ago BioNxt Advances Towards Human Trials with ODF Cladribine for MS Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Drug Delivery Technology Pharmaceutical Market
Published on 12/05/2025 at 17:00, 10 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 25 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 25 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour 35 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 16:25, 44 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:00, 1 hour 9 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 9 minutes ago EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 15:10, 1 hour 59 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 59 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 11 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 8 hours 25 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 8 hours 25 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
